Delcath CEO Hobbs takes top spot on Capella's board

June 18, 2010 by MassDevice staff

Eamonn Hobbs, CEO of Delcath Systems, is tapped to be Irish stent maker Capella Inc.'s chairman of the board.

Capella logo

Eamonn Hobbs took over as board chairman for Irish stent-maker Capella Inc.

Hobbs is CEO of Delcath Systems Inc. (NSDQ:DCTH), a New York-based manufacturer of arterially administered cancer treatments, and was CEO and co-founder of AngioDynamics (NSDQ:ANGO). Hobbs fills the position of former Capella chairman Dr. Wolfgang Oster, a managing partner at PolyTechnos Venture-Partners GmbH.

Capella is developing treatments for coronary bifurcation disease, including its Sideguard sidebranch coronary stent and its delivery system, according to a press release.

Hobbs joins former Boston Scientific chief science officer Art Rosenthal, who was named CEO of Cappella in June of 2009.